A Hong Kong biotech company said its therapeutic HIV vaccine showed “promising” results in a recent clinical trial, taking it ...

HONG KONG SAR - Media OutReach Newswire – 12 November 2024 - Immuno Cure BioTech (" Immuno Cure "), a clinical-stage ...

Nigeria, South Africa, Zambia, Zimbabwe, Tanzania, Uganda, Kenya, and Mozambique have begun locally-led HIV vaccine research ...

The project, aptly named BRILLIANT, an acronym for “Bringing Innovation to Clinical and Laboratory Research to End HIV in ...

Continuing their journey to develop a vaccine for HIV, Oregon Health & Science University researchers have identified a gene ...

Immuno Cure is a clinical stage biotechnology group based in the Hong Kong Science Park, focusing on research and development ...

A virologist at the University of Nebraska-Lincoln, Qingsheng Li, was awarded $3.5 million to advance his work on a vaccine ...

One of the most sought-after vaccines in medicine is the HIV vaccine. When HIV was first discovered in 1981, scientists were optimistic that they would be able to develop a vaccine in a few years.

The federal government yesterday formally announced the commencement of the HIV Vaccine Innovation, Science, and Technology ...

Nigeria, South Africa, Zambia, Zimbabwe, Tanzania, Uganda, Kenya, and Mozambique have begun locally-led HIV vaccine research and development. This was disclosed at a press briefing in Abuja ...

The National Agency for the Control of AIDS (NACA has expressed enthusiasm over the involvement of an indigenous research institute in groundbreaking HIV vaccine development efforts. This comes ...